Lupin’s subsidiary Lupin Pharmaceutical has received the 2011 DIANA award by the Healthcare Distribution Management Association (HDMA) for the best overall generic product manufacturing among those companies with the sale of up to $100 million in the healthcare distribution market.
HDMA distributor members selected the DIANA award winners to recognize companies that continually foster strong trading partner relationship with the Association’s primary distributor members by creating exceptional business practices that advance trade relationship and benefit the entire US healthcare supply chain.
Lupin is an innovation led transnational pharmaceutical company producing wide range of quality, affordable generic and branded formulations and API’s. Currently the company has significant presence in the cardiovascular, diabetology, asthma, pediatrics, CNS, CI, anti infective, NSAIDs addition to holding global leadership position in the anti TB and cephalosporins space.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: